Get started
Author

Markus Hengstschläger

Observed names: Hengstschläger, Markus, M HENGSTSCHLAGER, M Hengstschlager, M Hengstschläger, M. Hengstschlager, M. Hengstschläger, MARKUS HENGSTSCHLÄGER, Markus Hengstschlaeger, Markus Hengstschlager, Markus Hengstschlaèger, Markus Hengstschläger
Observed institutions: University of Vienna, National Institutes of Health, University of Dundee, University of Washington Medical Center, Vienna General Hospital, Yale University, Dana-Farber Cancer Institute, Wunschbaby Institut für Kinderwunsch, Dana-Farber/Harvard Cancer Center, Vienna Biocenter, Centre international de recherche sur le cancer, ISREC Foundation, Medical University of Vienna
ORCID: 0000-0002-3342-7583
Observed ORCID: 0000-0002-3342-7583
OpenAlex ID: A5025032130
In vitro cell migration and invasion assays
2012 · Nina Kramer, Angelika Walzl, et al. · Mutation Research/Reviews in Mutation Research · 1,165
Regulation of innate immune cell function by mTOR
2015 · Thomas Weichhart, Markus Hengstschläger, et al. · Nature reviews. Immunology · 831
The TSC-mTOR Signaling Pathway Regulates the Innate Inflammatory Response
2008 · Thomas Weichhart, Giuseppina Costantino, et al. · Immunity · 801
PDF
Comparison of cancer cells cultured in 2D vs 3D reveals differences in AKT/mTOR/S6-kinase signaling and drug response
2016 · Angelika Riedl, Michaela Schlederer, et al. · Journal of Cell Science · 388
PDF
Cancer-associated fibroblast-derived WNT2 increases tumor angiogenesis in colon cancer
2019 · Daniela Unterleuthner, Patrick Neuhold, et al. · Angiogenesis · 299
PDF
Chronic signaling via the metabolic checkpoint kinase mTORC1 induces macrophage granuloma formation and marks sarcoidosis progression
2017 · Monika Linke, Ha Thi Thanh Pham, et al. · Nature Immunology · 287
The role of the placenta in fetal exposure to heavy metals
2012 · Claudia Gundacker, Markus Hengstschläger · Wiener Medizinische Wochenschrift · 282
mTORC 1 and mTORC 2 as regulators of cell metabolism in immunity
2017 · Monika Linke, Stephanie Deborah Fritsch, et al. · FEBS Letters · 274
PDF
Albumin is the major carrier protein for PFOS, PFOA, PFHxS, PFNA and PFDA in human plasma
2020 · Martin Forsthuber, Andreas Marius Kaiser, et al. · Environment International · 273
PDF
Cytoplasmic and nuclear distribution of the protein complexes mTORC1 and mTORC2: rapamycin triggers dephosphorylation and delocalization of the mTORC2 components rictor and sin1
2008 · M. Rosner, M. Hengstschlager · Human Molecular Genetics · 233
PDF
Role of the Tuberous Sclerosis Gene-2 Product in Cell Cycle Control
1997 · Thomas Soucek, Oliver Pusch, et al. · Journal of Biological Chemistry · 191
Activation of the human anaphase-promoting complex by proteins of the CDC20/Fizzy family
1998 · Edgar R. Kramer, Christian Gieffers, et al. · Current Biology · 178
PDF
Inactivation of the cyclin-dependent kinase inhibitor p27 upon loss of the tuberous sclerosis complex gene-2
1998 · Thomas Soucek, Raymond S. Yeung, et al. · Proceedings of the National Academy of Sciences · 177
Amniotic fluid cells and human stem cell research: a new connection.
2002 · Andrea-Romana Prusa, Markus Hengstschlager · PubMed · 174
mTOR phosphorylated at S2448 binds to raptor and rictor
2009 · M. Rosner, N. Siegel, et al. · Amino Acids · 162
Modeling human carcinomas: Physiologically relevant 3D models to improve anti-cancer drug development
2014 · Christine Unger, Nina Kramer, et al. · Advanced Drug Delivery Reviews · 157
The tuberous sclerosis gene products hamartin and tuberin are multifunctional proteins with a wide spectrum of interacting partners
2008 · Margit Rosner, Michaela Hanneder, et al. · Mutation Research/Reviews in Mutation Research · 147
Inhibition of mTOR blocks the anti-inflammatory effects of glucocorticoids in myeloid immune cells
2011 · Thomas Weichhart, Michael Haidinger, et al. · Blood · 141
PDF
The relevance of the individual genetic background for the toxicokinetics of two significant neurodevelopmental toxicants: Mercury and lead
2010 · Claudia Gundacker, Martin Gencik, et al. · Mutation Research/Reviews in Mutation Research · 141
Neurogenic cells in human amniotic fluid
2004 · Andrea-Romana Prusa, Erika Marton, et al. · American Journal of Obstetrics and Gynecology · 139
Autocrine WNT2 signaling in fibroblasts promotes colorectal cancer progression
2017 · N Kramer, J Schmöllerl, et al. · Oncogene · 138
IL1R1+ cancer-associated fibroblasts drive tumor development and immunosuppression in colorectal cancer
2023 · E. Koncina, M. Nurmik, et al. · Nature Communications · 135
PDF
Merging high-quality biochemical fractionation with a refined flow cytometry approach to monitor nucleocytoplasmic protein expression throughout the unperturbed mammalian cell cycle
2013 · Margit Rosner, Katharina Schipany, et al. · Nature Protocols · 129
mTOR-Mediated Regulation of Dendritic Cell Differentiation and Function
2016 · Nyamdelger Sukhbaatar, Markus Hengstschläger, et al. · Trends in Immunology · 128
IGFBP7, a novel tumor stroma marker, with growth-promoting effects in colon cancer through a paracrine tumor–stroma interaction
2014 · C Rupp, M Scherzer, et al. · Oncogene · 123
Works count: 292
Citation count: 12,970
H-index: 56
I10-index: 182
Year
Topic
Type